NASDAQ:CRBU | Free Cash Flow | Caribou Biosciences, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$26.98M$72,000.00-$27.06M
2025-12-31-$20.82M-$216,000.00-$21.04M
2025-03-31-$36.73M$1.04M-$37.77M
2024-12-31-$35.47M$518,000.00-$35.99M
2024-03-31-$37.2M$1.45M-$38.65M
2023-12-31-$21.38M$2.28M-$23.66M
2023-03-31-$27.94M$2.03M-$29.97M
2022-12-31-$25.04M$1.76M-$26.8M
2022-03-31-$21.67M$723,000.00-$22.4M
2021-12-31-$21.39M$685,000.00-$22.07M
2021-03-31$20.31M$22,000.00$20.29M
2020-12-31-$8.08M$27,000.00-$8.1M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$110.99M$1.36M-$112.35M
2024-12-31-$138.2M$4.88M-$143.08M
2023-12-31-$93.29M$11.61M-$104.9M
2022-12-31-$90.97M$6.45M-$97.42M
2021-12-31-$32.52M$2.12M-$34.64M
2020-12-31-$33.22M$317,000.00-$33.53M
2019-12-31-$32.01M$884,000.00-$32.89M